National Institute of Biomedical Research

Recent papers from National Institute of Biomedical Research

1. Quantitative facial phenotyping and age-associated differences in Sickle cell disease using interpretable machine learningPLOS Digital Health · 2026
2. Early epidemiological and spatial assessment of the Bundibugyo virus outbreak 2026Science · 2026
3. Genetic diversity of adenoviruses in humans and wild non-human primates from the Mabali Reserve (DRC), including a divergent adenovirus cluster in Cercopithecus wolfiVirology Journal · 2026
4. Genomic characterization of rare Salmonella enterica serovars in free-ranging African primates from the Democratic Republic of the CongoBMC Microbiology · 2026
5. Hepatitis E infection among patients with acute febrile jaundice in the Democratic Republic of the Congo: a nationwide cross-sectional studyBMC Infectious Diseases · 2026
6. Early detection of immunoglobulin A against a vaccine backbone protein enables fast, durable, and objective identification of individuals vaccinated against Ebola virusEBioMedicine · 2026
7. MonkeypoxThe Lancet · 2022
8. Impact of praziquantel treatment and early reinfection patterns in a mixed Schistosoma mansoni and Schistosoma haematobium infection focus in the Democratic Republic of CongoPLoS neglected tropical diseases · 2026
9. Neutralizing antibody evidence of dengue and chikungunya virus exposure in macaques from an urban–forest fringe in Peninsular MalaysiaTropical Medicine and Health · 2026
10. Endogenous anti-Ebola virus GP 1,2 antibodies interfere with detection of secreted glycoprotein in the blood of EVD patientsJournal of Virology · 2026
11. From isolation to burial: dignity in the Bundibugyo virus disease responseThe Lancet · 2026
12. Plant extracts as alternatives for chemical disinfectants in veterinary settings in seven sub-Saharan African countriesFrontiers in Veterinary Science · 2026
13. Early insights into predicted efficacy of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreakNature Communications · 2026
14. Bioactive compounds from Tetradenia riparia and Tetracera poggei: antioxidant activity, UPLC-QTOF-MS phytochemical profiling, and in silico targeting of the RNA-binding protein DRBD18 of Trypanosoma bruceiFrontiers in Pharmacology · 2026
15. Challenges and Adaptations in COVID-19 Seroprevalence Surveys: Insights from Kinshasa, the Democratic Republic of the CongoMicroorganisms · 2026
16. Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus–Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort studyThe Lancet · 2026
17. Integrating responders’ mental health into the Ebola outbreak responseThe Lancet · 2026
18. Phylogenetic analysis of the 2025 Ebola outbreak in the Democratic Republic of the CongoNature Communications · 2026
19. Embedding social and behavioural science across and beyond Ebola clinical trials: a critical research priorityThe Lancet Global Health · 2026
20. Validation of a Bayesian Ebola Diagnostic Model Using Data from the Tenth Epidemic of 2018 to 2020 in the Democratic Republic of CongoDiagnostics · 2026